NCT07200583 2025-11-18
PAIA-Haplo
Fujian Medical University
Completed
Clinical Trials
3 trialsNCT00440479 2015-04-16
ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.
Janssen-Cilag B.V.
Completed
NCT00440765 2014-01-14
VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
Janssen-Cilag B.V.
Completed